Table 1 Comparison of general information between the two groups
Groups | Experimental group (n = 76) | Control group (n = 72) | t / Z / χ2 | P |
|---|---|---|---|---|
Gender (n, %) | Â | Â | 3.190a | 0.074 |
 Male | 47(61.8) | 34(47.2) |  |  |
 Female | 29(38.2) | 38(52.8) |  |  |
Age [Years, M (P25, P75)] | 67(63,72) | 67(63,73) | -0.354b | 0.724 |
BMI [Kg/m2, M (P25, P75)] | 22.4(21,24) | 22.4(21,23.6) | -0.524b | 0.600 |
Educational attainment (n, %) | Â | Â | 0.014a | 0.993 |
Primary education | 2(42.1) | 30(41.7) | Â | Â |
Secondary education | 36(47.4) | 34(47.2) | Â | Â |
Higher education | 8 (10.5) | 8 (11.1) | Â | Â |
Type of disease (n, %) | Â | Â | 0.039a | 0.998 |
Kidney cancer | 30(39.5) | 28(38.9) | Â | Â |
Bladder Cancer | 20(26.3) | 19(26.4) | Â | Â |
Prostate Cancer | 10(13.2) | 9(12.5) | Â | Â |
Ureteral Cancer | 5 (6.6) | 5 (6.9) | Â | Â |
Renal pelvis cancer | 7 (9.2) | 7 (9.7) | Â | Â |
Other | 4 (5.3) | 4 (5.6) | Â | Â |
Comorbidities (n, %) | Â | Â | 0.037a | 0.847 |
 Yes | 57(75.0) | 53(73.6) |  |  |
 No | 19(25.0) | 19(26.4) |  |  |